Biolin Scientific and Nanion Technologies have entered into a licensing agreement
Posted on February 5, 2015
Stockholm and Munich February 5, 2015 – Biolin Scientific Holding AB, Sweden and Nanion Technologies GmbH, Germany today announce that the parties have entered into a licensing agreement. Biolin Scientific has agreed to grant a non-exclusive license for the key patent related to performing multi-hole, high-throughput ion channel screening to Nanion Technologies in exchange for an undisclosed license fee. The non-exclusive license will provide Nanion Technologies with freedom to operate for the entire life time of the patents.
The patent describes a method for ensuring high quality data by analyzing multiple cells and thus multiple sets of ion channels under one experimental condition, thus providing extremely high quality data and a truly high-throughput screening method.
Johan von Heijne, President and CEO of Biolin Scientific states, “This deal affirms our commitment to invest in high-throughput screening using automated patch clamping, and our intent to vigorously protect our broad range of innovations and intellectual property rights. We are committed to our full range of brands including Sophion, Q-Sense, Attension and KSV NIMA branded products”.
Niels Fertig, CEO of Nanion Technologies comments, “The license agreement is fully in-line with our long-term strategy to safeguard our ability to continue to develop new and exciting products in the field of automated patch clamping”.
About Biolin Scientific
Biolin Scientific is a leading Nordic instrumentation company with revenues of 240 million SEK and part of Ratos AB (publ). Our premium solutions help the pharmaceutical industry to discover new drugs and treatments. Companies working with energy, chemicals and advanced materials use our technologies for material characterization and quality control. Our precision instruments also support academic research institutes in their studies of the frontiers of science and technology.
Biolin Scientific proprietary systems are based on nanotechnology and advanced measurement techniques, which have earned leadership in several industries through their commitment to scientific excellence and continuous product development. Our commitment to customer service and application support is a key feature of our operations. We focus on working together with customers and building long-lasting relations. Today, Biolin Scientific provides products and services in more than 70 countries around the world. Our portfolio consists of the following brands: Attension, KSV NIMA, Q-Sense and Sophion.
About Nanion Technologies
Nanion Technologies was founded in 2002 as a spin-off from the University of Munich, Center for Nanoscience (CeNS). Over the last 13 years it has grown to a strong company with over 80 employees worldwide. Nanion has its headquarters in Munich, Germany, and has daughter companies in the USA and China, with distribution partners in 7 other countries, including Japan. Nanion has been recognized for its quality and innovation by being twice nominated for the Federal President’s Award for Technology and Innovation (Deutscher Zukunftspreis) in 2007 and 2014. The company has become known for its high quality instruments for ion channel research (Port-a-Patch, Patchliner and SyncroPatch product families) and has over the years expanded its product range to include cardiotoxicity screening (CardioExcyte 96), parallel bilayer recordings (Orbit 16), and parallel membrane transporter protein recordings (SURFE2R). Since 2014, Nanion carries Axion’s multi-electrode array (MEA) systems in Europe and China.
Johan von Heijne
CEO Biolin Scientific
+46 70 595 15 10
CEO Nanion Technologies GmbH
+44 89 218997972